Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

Executive interview with Edison TV

In this video, Dr Koch discusses the increasingly positive sentiment towards the biotech sector, following the recent JP Morgan healthcare conference. He also covers some of the transactions that have benefited BB Biotech’s portfolio in recent periods, provides a summary of how the company uses agentic AI to support its investment process and outlines what to expect for BB Biotech in the year ahead.
28.01.2026 - Christian Koch
BB Biotech – executive interview (22 January 2026)

This might also interest you

  • BB Biotech AG

    BB Biotech AG (SIX) (CHF)
    ISIN-No.: CH0038389992YTD: 6.90%Active share: 80.67Anzahl Positionen: 22
    Launch date: 16. November 1993